We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CALT market cap is 1.07B. The company's latest EPS is SEK -17.3716 and P/E is -0.43.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 191.35M | 269.38M | 294.59M | 451.56M | 295.48M |
| Operating Income | -180.07M | -75.17M | -159.57M | 41.76M | -203.83M |
| Net Income | -187.53M | -91.93M | -168.36M | -18.37M | -246.16M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Revenue | 184.83M | 874k | 229.35M | 802.88M | 1.21B |
| Operating Income | -27.88M | -382.22M | -522.84M | -414.81M | -409.42M |
| Net Income | -32.58M | -433.49M | -500.29M | -412.27M | -466.19M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 1.79B | 1.71B | 1.61B | 1.86B | 1.69B |
| Total Liabilities | 1.2B | 1.2B | 1.26B | 1.52B | 1.57B |
| Total Equity | 589.4M | 504.37M | 352.44M | 334.81M | 120.15M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Total Assets | 845.2M | 1.51B | 1.46B | 1.95B | 1.86B |
| Total Liabilities | 57.13M | 250.15M | 451.63M | 1.19B | 1.52B |
| Total Equity | 788.07M | 1.26B | 1.01B | 766.26M | 334.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -231.94M | -394.97M | -457.5M | -434.66M | -198.21M |
| Investing | -2.91M | -3.97M | -11.39M | -13.75M | -3.86M |
| Financing | -2.97M | -5.98M | -8.87M | 199.65M | -5.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
| Operating | -71.01M | -309.18M | -461.59M | -311.35M | -434.66M |
| Investing | -18.07M | -172.61M | -24.34M | -5.14M | -13.75M |
| Financing | 198.84M | 768.56M | 435.16M | 575.99M | 199.65M |
| Market Cap | 1.07B |
| Price to Earnings Ratio | -0.43 |
| Price to Sales Ratio | 0.17 |
| Price to Cash Ratio | 0.21 |
| Price to Book Ratio | 0.61 |
| Dividend Yield | - |
| Shares Outstanding | 26.84M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 40 (66.66%) |
| Company Name | Calliditas Therapeutics AB |
| Address |
kungsbron 1, c8 stockholm SE-111 22 |
| Website | https://www.calliditas.se |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
